News
TTOO
2.940
-2.97%
-0.090
Weekly Report: what happened at TTOO last week (0408-0412)?
Weekly Report · 2d ago
Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more
This week marks the beginning of earnings season. Bank of America (BAC) and Goldman Sachs (GS) are among the major companies set to report their quarterly results. Netflix, Procter & Gamble, Johnson & Johnson and others will also report in the week of April 15.
Seeking Alpha · 3d ago
T2 Biosystems shareholders vote to convert $15M CRG debt into equity
T2 Biosystems shareholders vote to convert $15M CRG debt into equity. Stockholders voted for the approval of the conversion of $15 million of its term loan with entities affiliated with CRG Servicing into T2 B biosystems equity. The company expects to reduce CRG's debt by 36 percent.
Seeking Alpha · 6d ago
T2 BIOSYSTEMS - STOCKHOLDERS VOTED FOR APPROVAL OF CONVERSION OF $15 MLN OF TERM LOAN WITH ENTITIES AFFILIATED WITH CRG INTO T2 BIOSYSTEMS EQUITY
Reuters · 6d ago
Press Release: T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity. Stockholders voted for the approval of conversion of $15 million of its term loan with entities affiliated with CRG Servicing LLC. T2 B biosystems is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes.
Dow Jones · 6d ago
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
T2 Biosystems, Inc. Is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. Stockholders voted for the approval of conversion of $15 million of its term loan into equity. The special meeting of stockholders took place on April 11, 2024.
Barchart · 6d ago
Weekly Report: what happened at TTOO last week (0401-0405)?
Weekly Report · 04/08 09:00
Weekly Report: what happened at TTOO last week (0325-0329)?
Weekly Report · 04/01 09:00
T2 Biosystems Reinforces Market Position with Extended Vizient Agreement
TipRanks · 03/28 20:53
T2 Biosystems extends contract with Vizient
Healthcare T2 Biosystems extends contract with Vizient through March 31, 2025. The products covered under the contract include the T2Dx Instrument, which detects sepsis-causing bacterial and fungal pathogens directly from whole blood. The company's stock is up 2% in pre-market trading.
Seeking Alpha · 03/28 13:36
Weekly Report: what happened at TTOO last week (0318-0322)?
Weekly Report · 03/25 09:00
T2 Biosystems Anticipates Breakthroughs and Extends NASDAQ Compliance
TipRanks · 03/20 13:32
T2 Biosystems Revolutionizes Infection Detection Efficiency
TipRanks · 03/18 13:23
T2 Biosystems Announces New Publication Highlighting The Clinical Benefits And Performance Of The T2Resistance Panel
T2 Biosystems' T2Resistance Panel is a rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The European study demonstrated high accuracy and faster detection times for the T2resistance Panel. The panel is commercially available in Europe under a CE mark and has been granted Breakthrough Device designation from the FDA.
Benzinga · 03/18 13:06
Weekly Report: what happened at TTOO last week (0311-0315)?
Weekly Report · 03/18 09:00
TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance
T2 Biosystems has until May 20 to maintain a closing market capitalization of at least $35 million for at least 10 consecutive trading days. The medical diagnostics company may convert $15 million of debt held by CRG into equity. The company may have to dilute shareholders to achieve this.
Investorplace · 03/12 19:16
Weekly Report: what happened at TTOO last week (0304-0308)?
Weekly Report · 03/11 09:00
Weekly Report: what happened at TTOO last week (0226-0301)?
Weekly Report · 03/04 09:00
Weekly Report: what happened at TTOO last week (0219-0223)?
Weekly Report · 02/26 09:00
12 Health Care Stocks Moving In Monday's Intraday Session
Applied Therapeutics stock rose 42.5% to $5.34 during Monday's regular session. Universe Pharmaceuticals (NASDAQ:UPC) shares moved upwards by 41.86%. AMN Healthcare Services (NYSE:AMN) stock declined by 20.7% during the session.
Benzinga · 02/19 17:30
More
Webull provides a variety of real-time TTOO stock news. You can receive the latest news about T2 Biosystems through multiple platforms. This information may help you make smarter investment decisions.
About TTOO
T2 Biosystems, Inc. is an in-vitro diagnostics company. The Company is focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. The Company is using its T2MR technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its primary commercial products include the T2Candida Panel and the T2Bacteria Panel. Its T2Candida Panel is a direct-from-blood test that identifies the lethal form of common bloodstream infections that cause sepsis and candidemia. Its T2Bacteria Panel is a direct-from-blood test that detects certain bacterial pathogens associated with sepsis. Its primary commercial products also include the T2Dx Instrument, the T2Resistance Panel, and the T2SARS-CoV-2 Panel.